Key terms
About KMDA
Kamada Ltd. is a biopharmaceutical company, which focuses on specialty plasma-derived therapeutic. It operates through the Proprietary Products and Distribution segments. The Proprietary Products segment covers the development, manufacture, and sale of plasma-derived protein therapeutics products. The Distribution segment covers the drug products in Israel, which are manufactured by third parties. The company was founded by David Tsur and Ralf Hahn on December 13, 1990 and is headquartered in Rehovot, Israel.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest KMDA news
May 09
6:37am ET
Buy Rating Affirmed for Kamada on Accelerated Trial Prospects and Strong Financial Performance
May 08
7:04am ET
Kamada raises FY24 revenue to $158M-$162M from $156M-$160M
May 08
7:04am ET
Kamada reports Q1 EPS 4c vs (4c) last year
May 01
7:32am ET
Kamada Ltd. Q1 Financial Results and Conference Call
Mar 07
6:26am ET
Strategic Partnerships and Product Portfolio Expansion Poise Kamada for Robust Growth
Mar 06
7:20am ET
Kamada issues letter to shareholders
Mar 06
7:03am ET
Kamada reports Q4 EPS 9c vs 7c last year
No recent press releases are available for KMDA
KMDA Financials
Key terms
Ad Feedback
KMDA Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
KMDA Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range